Federica Loscocco

Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

Martina Chiarucci, Sara Paolasini, Alessandro Isidori et al. · Frontiers in Oncology · 2021 · 38 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +14

Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib

Federica Loscocco, Giuseppe Visani, Annamaria Ruzzo et al. · Frontiers in Oncology · 2021 · 20 citations · Full text

Medicine, Genetics, Pharmacotherapy +17

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia

Giuseppe Visani, Anita Manti, Laura Valentini et al. · Leukemia Research · 2016 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +14

Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study

Giuseppe Visani, Felicetto Ferrara, Francesco Di Raimondo et al. · Leukemia Research · 2017 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

A Novel High Dose Chemotherapy Strategy with Bendamustine In Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: a Phase I-II Study on 44 Patients

Giuseppe Visani, Lara Malerba, Pietro Maria Stefani et al. · Blood · 2010 · 14 citations

Medicine, Oncology, Pharmacology +16